AIMM has partnered with Apexus, the HRSA-designated Prime Vendor for the 340B Drug Pricing Program, and ASHP (American Society of Health-System Pharmacists) to offer the national A3 Collaborative, a year-long learning experience to help health care providers succeed in the new era of value-based payment programs. The A3 Collaborative initially launched in the Spring of 2017 and has supported more than 100 health systems and organizations implement CMM operations, scale and spread services, and for some, successfully install financial arrangements to ensure sustainability.
As a member of the A3 Collaborative, health care organizations participate in a 12-month transformational experience that will establish a new strategic capability. An implementation team will be formed by each organization to rapidly put in place a working medication management program, or to focus on accelerating the scale and spread of one already in place.
AIMM will not immediately resume another A3 Collaborative offering this Fall. Going forward, AIMM and partners will work to redesign the collaborative to address the technical and policy challenges of achieving full scale CMM, particularly in light of the evolving healthcare transformation due to COVID-19. We envision an A3 Collaborative that can help communities:
- Identify and engage populations who require CMM for successful health outcomes,
- Establish CMM operations at scale, across health care systems, regionally, and statewide,
- Generate innovative value-based payment arrangements crafted regionally and locally to finance these service delivery models, and
- Continue to evolve CMM operations as part of integrated delivery systems.
View a list of Participating Organizations with the A3 Collaborative
Celebrating the success of the A3 Collaborative and preparing for the next evolution of CMM, click here.